2.5mgCancer

Letase

Letase 2.5mg Tablet

Letrozole

INNVOTEK PHARMACEUTICALS

Drug Identity

Active Ingredient
Letrozole
Drug Class
Endocrine Hormone Therapy
ATC Code
L02BG04
Status
Essential Medicine

How to Take It

Dosage information not available for this product.

Safety Alerts

Pre-menopausal women, very severe hepatic impairment

Important Warnings

Very severe renal impairment
Susceptibility to osteoporosis

Side Effects

Alopeciaanorexiaappetite increasearthralgiabone fractureconstipationdepressiondiarrhoeadizzinessdry skindyspepsiafatigueheadachehot flusheshypercholesterolaemia

Pregnancy & Lactation

Pregnancy
Positive evidence of risk: Avoid
Lactation
Contraindicated. Discontinue breast-feeding

Price Intelligence

Rs 4,092.78
DRAP approved maximum price · per pack of 10 · approved 01 Jul, 2025
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper pack of 10Rs 4,092.78

Should you consider an alternative?

Other options containing Letrozole, and what they are not.

For pharma professionalsCompany, market and opportunity intelligence

Company

137
brands
132
molecules
1
alerts

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.